Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Genocea Biosciences (GNCA) PT Lowered to $2 at Cowen
-
Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results
-
Genocea Biosciences (GNCA) EN-003 Has >$700MM Peak Sales Potential - Cowen
-
Genocea to Present at the Cowen and Company 37th Annual Health Care Conference
-
Genocea Reports Fourth Quarter and Year-End 2016 Financial Results
-
Pre-Open Stock Movers 03/31: (GNCA) (MDVN) (MNOV) Higher; (EGLE) (PRGS) (MOV) Lower (more...)
-
Genocea to Present at the Cowen and Company 36th Annual Health Care Conference
-
Cowen Reiterated Buy on Genocea Biosciences (GNCA) Following 6 Month Follow-Up Data on GEN-003
-
Genocea Biosciences, Inc. Announces Closing of $50 Million Public Offering of Common Stock
-
Genocea Biosciences (GNCA) 3.85M Common Stock Offering Prices at $13/Share
-
Genocea Biosciences, Inc. Announces Pricing of $50 Million Public Offering
-
Genocea Biosciences, Inc. Commences Public Offering of Common Stock
-
Genocea Biosciences, Inc. Announces Closing of $51.7 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Genocea Biosciences (GNCA) Prices 5.45M Common Share Offering at $8.25/Share
-
Genocea Biosciences, Inc. Announces Pricing of $45 Million Public Offering
-
Genocea Biosciences (GNCA) Plans Common Stock Offering
-
Genocea Biosciences, Inc. Commences Public Offering of Common Stock
-
Genocea Biosciences (GNCA) Begins 3.4M Common Stock Offering
-
Cowen Starts Genocea Biosciences (GNCA) at Outperform
-
Genocea Biosciences (GNCA) IPO Opens Modeslty Lower after Weak Pricing
-
Genocea Biosciences (GNCA) Files $75M IPO

